Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide for Refractory Hypoglycemia in Insulin-Producing Pancreatic NET
NCT02779257Phase 4Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Apr 2016
- Primary completion
- Jun 2016
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 4 trial of pasireotide LAR in hypoglycemia, sponsored by University of Maryland, Baltimore. Planned start Apr 2016; status: withdrawn.
02
Drugs
pasireotide LAR
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02779257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779257.